BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.F317L - CISMeF
BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.F317LNCIt concept
Preferred Label : BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.F317L;
NCIt synonyms : BCR/ABL1 F317L Mutation; BCR/ABL Phe317Leu Mutation; BCR-ABL1 F317L Mutation; BCR/ABL1 Phe317Leu Mutation; BCR-ABL1 Phe317Leu Mutation; BCR/ABL1 Fusion Protein with ABL1 NP_005148.2:p.Phe317Leu; BCR/ABL Fusion Protein with Phe317Leu; BCR/ABL1 Fusion Protein with NP_005148.2:p.Phe317Leu; BCR/ABL1 Fusion Protein with NP_005148.2:pF317L; BCR-ABL F317L Mutation; BCR/ABL F317L Mutation; BCR/ABL Fusion Protein with F317L; BCR-ABL Phe317Leu Mutation; BCR::ABL1 Fusion Protein with ABL1 NP_005148.2:p.F317L;
NCIt related terms : F317L;
NCIt definition : A fusion protein encoded by the BCR/ABL1 fusion gene with ABL1 NM_005157.4:c.951C
A, c.951C G or c.949T C mutation. This protein is comprised of the N-terminus of the
breakpoint cluster region protein fused to almost the entire tyrosine-protein kinase
ABL1 protein where the phenylalanine at position 317 of the ABL1 protein has been
replaced by leucine.;
NCIt note : The position of the amino acid substitution is denoted by its location in the tyrosine-protein
kinase ABL1 protein sequence (NCBI Reference Sequence: NP_005148.2) and not its location
in the fusion protein.;